Treatment outcomes and quality-of-life issues for patients treated with prostate brachytherapy.
The increasing popularity of brachytherapy for treatment of early-stage prostate cancer requires oncology nurses to have a comprehensive knowledge of the disease, its treatment, and management of side effects. Because quality-of-life (QOL) issues have become an important consideration in treatment selection for many patients, oncology nurses must have a thorough understanding of these QOL issues and their management. Armed with knowledge about prostate brachytherapy and its effect on QOL, oncology nurses can offer accurate information and evidence-based symptom management techniques to patients undergoing brachytherapy for prostate cancer.
Abel
Laurie
L
Schifone@wheelinghosp.com
Dafoe-Lambie
Jane
J
Butler
Wayne M
WM
Merrick
Gregory S
GS
D000368:Aged; D001707:Biopsy, Needle; D001918:Brachytherapy / Q000009:adverse effects* / Q000379:methods*; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009730:Nursing Assessment; D009859:Oncology Nursing / Q000379:methods; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000401:mortality / Q000451:nursing* / Q000473:pathology / Q000532:radiotherapy*; D011788:Quality of Life; D011832:Radiation Injuries / Q000453:epidemiology* / Q000517:prevention & control; D018570:Risk Assessment; D018434:Sickness Impact Profile; D015996:Survival Rate; D016896:Treatment Outcome